Glenmark Launches Generic Eye Itch Treatment in US
Glenmark Pharmaceuticals' US subsidiary has launched a generic eye itch treatment, Olopatadine Hydrochloride Ophthalmic Solution (OTC), addressing growing market demand.

New Delhi, Aug 19 (PTI) Glenmark Pharmaceuticals on Monday said its US-based subsidiary has introduced a generic medication used for eye itching.
Glenmark Therapeutics Inc, USA has launched Olopatadine Hydrochloride Ophthalmic Solution (OTC) in the US market, the Mumbai-based drug maker said in a regulatory filing.
Fabio Moreno, Head of OTC Sales & Marketing, Glenmark Pharmaceuticals Inc, said the launch of Olopatadine Ophthalmic Solution (USP, 0.1 per cent), addresses a growing demand for a new supplier in this category.
"This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers," Moreno said.
Glenmark Therapeutics Inc, USA has launched Olopatadine Hydrochloride Ophthalmic Solution (OTC) in the US market, the Mumbai-based drug maker said in a regulatory filing.
Fabio Moreno, Head of OTC Sales & Marketing, Glenmark Pharmaceuticals Inc, said the launch of Olopatadine Ophthalmic Solution (USP, 0.1 per cent), addresses a growing demand for a new supplier in this category.
"This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers," Moreno said.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 6.95 ( -0.14)
- 43575671
- Spicejet Ltd.
- 45.41 ( -0.15)
- 43045653
- Sunshine Capital
- 0.71 ( -4.05)
- 32614254
- Guj. Toolroom Lt
- 1.59 ( -4.79)
- 15618377
- Srestha Finvest
- 0.55 ( -1.79)
- 15325263